Summary
Plasmin, a serine protease, was recently found to be involved in corneal ulcerative processes in humans and rabbits. In our experiments, plasmin activity was found in the tear fluid after mechanical and chemical damage of the rabbit cornea, such as de-epithelization and burning with alkali. The plasmin concentrations in the tear fluid were dependent on the severity of injury. The highest plasmin activity (2.0–3.0 μg ml−1) occurred after severe alkali damage to large areas of the cornea, and the lowest activity (0.4–1.0 μg ml−1) after mechanical injury (de-epithelization).
Plasmin concentrations up to 1.0 μ ml−1 were associated with increased activities of lysosomal hydrolases in epithelial cells and keratocytes beneath the epithelium. Plasmin activities increased as the inflammatory reaction developed. When plasmin activity in the tear fluid was higher than 1.0 μg ml−1, inflammatory cells were found in the corneal stroma. Levels of 1.5–2.0 μg ml−1 were connected with higher numbers of inflammatory cells (particularly polymorphonuclear leukocytes) with increased activities of lysosomal hydrolases. Very high plasmin activities (2.5–3.0 μg ml−1) accompanied corneal ulcerative processes.
The local application of aprotinin (Trasylol, Bayer), an inhibitor of plasmin, and also of some other proteases, was found to be necessary for the healing of severe corneal injuries in which highly elevated plasmin activity in the tear fluid and inflammatory cellulization of the cornea occurred (severe damage). It was beneficial in cases in which medium plasmin activity occurred in the tear fluid and inflammatory changes in the cornea were not too extensive. If used very early after injury, aprotinin prevents the appearance of high plasmin activity in the tear fluid, reduces the invasion of inflammatory cells into the corneal stroma, and accelerates the healing. Even the corneal transparency is restored in many cases.
Similar content being viewed by others
References
Barlati, S., Marchina, E., Quaranta, C. A., Vigasic, F. & Semeraro, F. (1990) Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair. Exp. Eye Res. 51, 1–9.
Berman, M., Leary, R. & Gage, J. (1980) Evidence for the role of plasminogen activator—plasmin in corneal ulcerations. Invest. Ophthalmol. Vis. Sci. 19, 1204–21.
Berman, M., Manseau, E., Law, M. & Aikene, D. (1983) Ulceration is correlated with the degradation of fibrin and fibronectin at the corneal surface. Invest. Ophthalmol. Vis. Sci. 24, 1358–76.
Berman, M., Kenyon, K., Hayashi, K. & L'Hernault, N. (1988) The pathogenesis of epithelial defects and stromal ulceration. In The Cornea: Transactions of the World Congress on the Cornea III (edited by Cavanagh, H. D.) pp. 35–43. New York: Raven Press.
Berta, A., Tozser, J. & Holly, F. J. (1990) Determination of plasminogen activities in normal and pathological human tears. The significance of tear plasminogen activators in the inflammatory and traumatic lesions of the cornea and the conjuctiva. Acta Ophthalmol. 68, 508–14.
Boisjoly, H. M., Sun, R., Giasson, M. & Beaulieu, A. (1990) Topical fibronectin and aprotinin for keratectomy wound healing in rabbits. Arch. Ophthalmol. 108, 1758–63.
Čejková, J. & Lojda, Z. (1986) Histochemistry of some proteases in the normal rabbit, pig and ox cornea. Histochemistry 84, 67–71.
Čejková, J., Lojda, Z., Salonen, E.-M. & Vaheri, A. (1989) Histochemical study of alkali-burned rabbit anterior eye segment in which severe lesions were prevented by aprotinin treatment. Histochemistry 92, 441–8.
Čejková, J., Lojda, Z., Vacík, J., Digenis, J. A. & Dropcová, S. (1992) Histochemical changes in the rabbit cornea and plasmin activity in the tear fluid during contact lens wear. Favourable influence of protease inhibitors (aprotinin, PC5, elastatinal). Histochemistry 97, 69–76.
Fritz, H. & Wunderer, G. (1983) Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneim. Forsch. 33, 479–94.
Hayashi, K., Berman, M., Smith, D., El-Ghatit, A., Pease, S. & Kenyon, K. R. (1991) Pathogenesis of corneal epithelial defects: role of plasminogen activator. Curr. Eye Res. 10, 381–98.
Jensen, O. L., Gluud, B. S. & Eriksen, H. O. (1985) Fibronectin in tears following surgical trauma to the eye. Acta Ophthalmol. 63, 346–50.
Lojda, Z. (1981) Proteinases in pathology. The usefulness of histochemical methods. J. Histochem. Cytochem. 29, 481–93.
Lojda, Z. (1984) Die Histochemie der Proteasen. Acta Histochem. (suppl) 30, 9–29.
Lojda, Z. (1985) The importance of protease histochemistry in pathology. Histochem. J. 17, 1063–89.
Lojda, Z., Gossrau, R. & Schiebler, T. H. (1979) Enzyme Histochemistry. A Laboratory Manual. Berlin: Springer.
Mcgovern, V. J. (1955) Reactions to injury of vascular endothelium with special reference to the problem of thrombosis. J. Pathol. Bacteriol 69, 283–5.
Saksela, O. (1981) Radial caseinolysis in agarose: a simple method for detection of plasminogen activator in the presence of inhibitory substances and serum. Anal. Biochem. 111, 276–82.
Salonen, E.-M., Tervo, T., Torma, E., Tarkkanen, A. & Vaheri, A. (1987) Plasmin in the tear fluid of patients with corneal ulcers: basis for new therapy. Acta Ophthalmol. 65, 3–12.
VanSetten, G.-B., Viinikka, L., Tervo, T., Pesonen, K., Tark-Kanen, A. & Perheentupa, J. (1989) Epidermal growth factor is a component of normal human tear fluid. Graefe's Arch. Clin. Exp. Ophthalmol. 227, 184–7.
Wang, H. M., Berman, M. & Law, M. (1985) Latent and active plasminogen activator in corneal ulceration. Invest. Ophthalmol. Vis. Sci. 26, 511–24.
Zieske, J. D. & Bukusoglu, G. (1991) Effect of protease inhibitors on corneal epithelial migration. Invest. Ophthalmol. Vis. Sci. 32, 2073–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Čejková, J., Lojda, Z., Dropčová, S. et al. The histochemical pattern of mechanically or chemically injured rabbit cornea after aprotinin treatment: relationships with the plasmin concentration of the tear fluid. Histochem J 25, 438–445 (1993). https://doi.org/10.1007/BF00157808
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00157808